Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant.
Int J Neuropsychopharmacol. 2022 Jan 12;25(1):85-88. doi: 10.1093/ijnp/pyab078.
Int J Neuropsychopharmacol. 2022.
PMID: 34791262
Free PMC article.
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?
Mathew SJ, Jha MK, Anand A.
Mathew SJ, et al.
JAMA Psychiatry. 2023 Dec 1;80(12):1187-1188. doi: 10.1001/jamapsychiatry.2023.3979.
JAMA Psychiatry. 2023.
PMID: 37878334
Item in Clipboard
Cite
Cite